Market Entry and Expansion

Entering a new country or segment can open significant growth – or tie up capital and management time for years. Stuart-Houghton Associates helps companies plan and execute market entry with the right balance of ambition and caution.

In medical devices, pharmaceuticals and healthcare, entry involves more than finding customers. Regulatory approval, reimbursement, distribution structures and clinical acceptance all shape what is possible and how fast.

Choosing the right markets

We compare options on objective criteria:

• Market size, growth and competitive landscape
• Regulatory requirements and approval pathways if applicable
• Reimbursement and pricing environment
• Distribution structures and key partners
• Local business practices and decision-making

The result is a clear, ranked view of where to go first, where to go later and where not to go at all.

The right entry model and partners

Direct export, distributors, licensing, joint ventures or your own subsidiary – each carries different costs, risks and levels of control. We recommend the model that fits your goals and resources. For many companies, the right local partner is the biggest success factor, so we identify, screen and assess distributors and strategic partners, and support first contacts and negotiations.

Launch and expansion

We help you build a launch plan with realistic milestones, adapt materials to local needs and, in healthcare, identify key opinion leaders and prepare the ground for reimbursement. Growth can also come from new segments or applications within existing markets – we show where your strengths can be extended.

Our team combines marketing, business development, expertise, research and data presentation, giving you hands-on, senior-level support from first screening to launch.